Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date |
Article Title |
Journal |
|---|---|---|---|
|
Omar Abdel-Rahman |
December 2018 | 5-Fluorouracil-Related Cardiotoxicity; Findings from Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer | Clinical Colorectal Cancer |
|
Chun Pan, Bo Cai, Lianming Wang |
May 2020 | A Bayesian approach for analyzing partly interval-censored data under the proportional hazards model | Statistical Methods in Medical Research |
|
Fatemeh Seyednasrollah, Devin C. Koestler, Tao Wang, Stephen R. Piccolo, Roberto Vega, Russell Greiner, Christiane Fuchs, Eyal Gofer, Luke Kumar, Russell D. Wolfinger, Kimberly Kanigel Winner, Chris Bare, Elias Chaibub Neto, Thomas Yu, Liji Shen, Kald Abdallah, Thea Norman, Gustavo Stolovitzky, Howard R. Soule, Christopher J. Sweeney, Charles J. Ryan, Howard I. Scher, Oliver Sartor, Laura L. Elo, Fang Liz Zhou, Justin Guinney, James C. Costello, and Prostate Cancer DREAM Challenge Community |
August 2017 | A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer | Journal of Clinical Oncology |
|
Zhen Su, Monica M. Bertagnolli, A. Oliver Sartor, Catherine E. Symonds, Hao Zhang, Martin J. Murphy |
June 2018 | A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) | Journal of Clinical Oncology |
|
N. Geifman, A.J Butte |
May 2016 | A Patient-Level Data Meta-Analysis of Standard-of-Care Treatments from Eight Prostate Cancer Clinical Trials | Nature Scientific Data |
|
Mehrad Mahmoudian, Fatemeh Seyednasrollah, Liisa Koivu, Outi Hirvonen, Sirkku Jyrkkio, Laura L. Elo |
May 2019 | A predictive model of overall survival in patients with metastatic castration-resistant prostate cancer | F1000 Research |
|
Wei-xiang Qi, Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen |
February 2020 | Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials | The Breast |
|
Omar Abdel-Rahman |
June 2019 | Asian Americans have better outcomes of non-metastatic gastric cancer compared to other United States racial groups: A secondary analysis from a randomized study | World Journal of Gastrointestinal Oncology |
|
Bethany Pitcher, Leila Khoja, Robert J. Hamilton, Kald Abdallah, Melania Pintilie, Anthony M. Joshua |
February 2017 | Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. | PLOS ONE |
|
Guru Sonpavdea, Gregory R.Pond, Arnoud J.Templeton, Abderrahim Fandi, Bertrand Tombale, Mark Rosenthal, Andrew J.Armstrong, Daniel P.Petrylakh |
June 2016 | Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel | European Urology |
|
Jeffrey West, Yongqian Ma, Paul K. Newton |
October 2018 | Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castration Resistant Prostate Cancer Treatment | Journal of Theoretical Biology |
|
Toby Wilkinson, Siddharth Sinha, Niels Peek and Nophar Geifman |
August 2019 | Clinical trial data reuse – overcoming complexities in trial design and data sharing | Trials |
|
Teemu D. Laajala, Justin Guinney, James C. Costello |
September 2017 | Community mining of open clinical trial data | Oncotarget |
|
Angela K. Green, Robert W. Corty, William A. Wood, Mathew Meeneghan, Katherine E. Reeder-Hayes, Ethan Basch, Matthew I Milowsky, Stacie B. Dusetzina |
May 2015 | Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone alone in Metastatic Castrate-resistant Prostate Cancer after Docetaxel Failure | The Oncologist |
